Oculogica, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Oculogica, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Oculogica, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 5, 2026 to Jun 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QEA appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 1477 S. Knowles Ave., #110f, New Richmond, WI, 54017, US. Recorded on K254086, decision dated Jun 5, 2026.
Device categories in this collection
Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EyeBOX SNAPK254086 | Oculogica, Inc. | 510(k) clearance | Jun 5, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
